Cost analysis of the Spanish renal replacement therapy programme

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3709-3714

  Villa, Guillermo ^a,b   Rodríguez Carmona, Ana ^c   Fernández Ortiz, Lucía ^a   Cuervo, Jesús ^a   Rebollo, Pablo ^a   Otero, Alfonso ^d   Arrieta, Javier ^e  

^a BAP Health Outcomes Research   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c UNIVERSITY OF A CORUÑA   (Spain)

^d Complejo Hospitalario de Ourense ^*  (Spain)

^e HOSPITAL DE BASURTO   (Spain)

Author keywords

cost analysis; end stage renal disease; haemodialysis; kidney transplantation; peritoneal dialysis

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH PROGRAM; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SPAIN;

COSTS AND COST ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL REPLACEMENT THERAPY; SPAIN;

EID: 80155198712     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr088     Document Type: Article

References (52)

1. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1): 1-266
2. ERA-EDTA. ERA-EDTA Registry Annual Report 2008. http:// www.era-edta-reg.org/ (11 January 2011, date last accessed)
3. Spanish Society of Nephrology. Spanish Registry of Renal Patients. Dialysis and Transplants in Spain 2009 Report. http://www. senefro.org/ (11 January 2011, date last accessed)
4. Alcázar R, Orte L, Otero GA. Advanced chronic kidney disease. Nefrología 2008; 28 (Suppl 3): 3-6
5. Otero A, De Francisco A, Gayoso P et al. Prevalence of chronic renal disease in Spain: Results of the EPIRCE study. Nefrología 2010; 30: 78-86
6. Navaneethan SD, Aloudat S, Singh S. A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol 2008; 9: 3
7. Alcázar R, Egocheaga MI, Orte L et al. SEN-SEMFYC consensus document on chronic kidney disease. Nefrología 2008; 28: 273-282
8. Otero A, Abelleira A, Gayoso P. Occult chronic kidney disease (OCKD) and cardiovascular risk factors. Epidemiologic study. Nefrologi ́a 2005; 25: 275-287
9. Peña JM, Logroño JM, Pernaute R et al. Late nephrology referral influences on morbidity and mortality of hemodialysis patients: A provincial study. Nefrología 2006; 26: 84-97
10. Chow KM, Szeto CC, Law MC et al. Impact of early nephrology referral on mortality and hospitalization in peritoneal dialysis patients. Perit Dial Int 2008; 28: 371-376
11. Shin SJ, Kim HW, Chung S et al. Late referral to a nephrologist increases the risk of uremia-related cardiac hypertrophy in patients on hemodialysis. Nephron Clin Pract 2007; 107: 139-146
12. Nakamura S, Nakata H, Yoshihara F et al. Effect of early nephrology referral on the initiation of hemodialysis and survival in patients with chronic kidney disease and cardiovascular diseases. Circ J 2007; 71: 511-516
13. Meyer A, Bunzemeier H, Hausberg M et al. Impact of different stages of chronic kidney disease on in-hospital costs in patients with coronary heart disease. Nephrol Dial Transplant 2008; 23: 1955-1960
14. Smith DH, Gullion CM, Nichols G et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15: 1300-1306
15. Pons R, Torregrosa E, Hernández-Jaras J et al. Estimation of the cost in the pharmacologic treatment of chronic renal failure. Nefrología 2006; 26: 358-364
16. Trivedi HS, Pang MM, Campbell A et al. Slowing the progression of chronic renal failure: Economic benefits and patients' perspectives. Am J Kidney Dis 2002; 39: 721-729
17. McLaughlin K, Manns B, Culleton B et al. An economic evaluation of early versus late referral of patients with progressive renal insufficiency. Am J Kidney Dis 2001; 38: 1122-1128
18. Gómez CG, Valido P, Celadilla O et al. Validity of a standard information protocol provided to end-stage renal disease patients and its effect on treatment selection. Perit Dial Int 1999; 19: 471-477
19. Little J, Irwin A, Marshall T et al. Predicting a patient's choice of dialysis modality: Experience in a United Kingdom renal department. Am J Kidney Dis 2001; 37: 981-986
20. Marrón B, Martínez-Ocaña JC, Salgueira M et al. Analysis of patient flow into dialysis: Role of education in choice of dialysis modality. Perit Dial Int 2005; 25 (Suppl 3): 56-59
21. Arrieta J, Bajo MA, Caravaca F et al. Guidelines of the Spanish Society of Nephrology. Clinical practice guidelines for peritoneal dialysis. Nefrología 2006; 26 (Suppl 4): 1-184
22. Salonen T, Reina T, Oksa H et al. Cost analysis of renal replacement therapies in Finland. Am J Kidney Dis 2003; 42: 1228-1238
23. Nakajima I, Akamatsu M, Tojimbara T et al. Economic study of renal transplantation: A single-center analysis in Japan. Transplant Proc 2001; 33: 1891-1892
24. Just PM, Riella MC, Tschosik EA et al. Economic evaluations of dialysis treatment modalities. Health Policy 2008; 86: 163-180
25. Baboolal K, McEwan P, Sondhi S et al. The cost of renal dialysis in a UK setting: A multicentre study. Nephrol Dial Transplant 2008; 23: 1982-1989
26. Peeters P, Rublee D, Just PM et al. Analysis and interpretation of cost data in dialysis: Review of Western European literature. Health Policy 2000; 54: 209-227
27. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies: An international review: Costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14 (Suppl 6): 31-41
28. Rodríguez-Carmona A, Pérez-Fontán M, Valdés-Cañedo F. Comparative study of the costs of different modes of dialysis. Nefrología 1996; 16: 539-548
29. Ponz E, Sato J, García M et al. Analysis of the economic management of a peritoneal dialysis program. Comparison with the hemodialysis program. Nefrología 1997; 17: 152-161
30. Hernández-Jaras J, García H, Bernat A et al. Approximation to cost analysis of various types of hemodialysis using relative value units. Nefrología 2000; 20: 284-290
31. Rodríguez CA, Pérez FM. Economic studies in dialysis. An essential tool for optimization of resources. Nefrología 2007; 27: 237-240
32. Villa G, Cuervo J, Ortiz LF et al. Forecasting Spanish renal replacement therapy trends from registry data: A quantile regression approach. Value in Health 2009; 12: 308
33. Spanish Society of Nephrology. Information Unit of the Kidney Disease Registers. http://www.senefro.org/ (11 January 2011, date last accessed)
34. Spanish National Transplant Organization. Data on organ donation and transplantation. http://www.ont.es/ (11 January 2011, date last accessed)
35. Oblikue Consulting eSalud healthcare cost database. eSalud healthcare cost database. http://www.oblikue.com/ (11 January 2011, date last accessed).
36. Spanish National Statistics Institute. INE Base. http://www.ine.es (11 January 2011, date last accessed)
37. Ortega T, Ortega F, Díaz-Corte C et al. The timely construction of arteriovenous fistulae: A key to reducing morbidity and mortality and to improving cost management. Nephrol Dial Transplant 2005; 20: 598-603
38. Rodríguez-Carmona A, Castro A, Pérez FM et al. Economic study of dialysis using the cost-per-procedure method according to clinical protocols. Nefrología 2007; 27: 359-369
39. Jadoul M, Poignet JL, Geddes C et al. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant 2004; 19: 904-909
40. United States Renal Data System. Annual Data Reports. http:// www.usrds.org (11 January 2011, date last accessed)
41. Escallada R, Arias M, De Francisco ALM. Public and private care as integrated models of treatment for chronic kidney failure. Nefrología 1995; 15: 403-410
42. Lacueva J, Antolín A, Santamaría C et al. Efectos del cambio de gluconato férrico a hierro sacarosa sobre la anemia en pacientes en hemodiálisis. León, Spain: XXVI Congreso de la Sociedad Espan ̃ola de Diálisis y Trasplante; 2004
43. Jansen MA, Hart AA, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046-1053
44. Lang SM, Bergner A, Topfer M et al. Preservation of residual renal function in dialysis patients: Effects of dialysis-technique-related factors. Perit Dial Int 2001; 21: 52-57
45. Coronel F, Herrero JA, Montenegro J et al. Erythropoietin requirements: A comparative multicenter study between peritoneal dialysis and hemodialysis. J Nephrol 2003; 16: 697-702
46. Moyano MJ, Salgueira M, Aresté N et al. Comparative study of PTFE grafts in forearm vs cuffed permanent catheters. Nefrología 2006; 26: 594-599
47. Rodríguez Hernández JA, López PJ, Piera L. Vascular access in Spain: Analysis of its distribution, morbidity, and monitoring systems. Nefrología 2001; 21: 45-51
48. Pérez-Contreras J, Sánchez MA, Rivera F et al. A prospective multicenter comparison of peritonitis in peritoneal dialysis patients aged above and below 65 years. Adv Perit Dial 2000; 16: 267-270
49. Marco JE, Rodríguez-Carmona A, Otero A et al. Modelo para la evaluación de costes en diálisis. Bilbao, Spain: V Jornadas de Gestión y Evaluación de Costes Sanitarios; 2000
50. Lamas J, Alonso M, Saavedra J et al. Costs of chronic dialysis in a public hospital: Myths and realities. Nefrología 2001; 21: 283-294
51. Drummond MF, O'Brien B, Stoddart GL et al. Methods for the Economic Evaluation of Health Care Programmes. Oxford, UK: Oxford University Press; 1997
52. Spanish National Institute of Social Security. http://www.seg-social. Es